Prothena公司2024年第四季度GAAP每股收益$(1.08)不及预期$(1.04),销售额$2.12百万不及预期$7.53百万

财报速递
21 Feb
Prothena公司(NASDAQ: PRTA)报告季度每股亏损$(1.08),未能达到分析师一致预期的$(1.04),差异为3.85%。 相比去年同期每股亏损$(1.26),这是一个14.29%的增长。公司报告季度销售额为$212万,未能达到分析师一致预期的$753万,差异为71.82%。相比去年同期的销售额$31.6万,这是一个571.84%的增长。

以上内容来自Benzinga Earnings专栏,原文如下:

Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(1.04) by 3.85 percent. This is a 14.29 percent increase over losses of $(1.26) per share from the same period last year. The company reported quarterly sales of $2.12 million which missed the analyst consensus estimate of $7.53 million by 71.82 percent. This is a 571.84 percent increase over sales of $316.00 thousand the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10